Astrazeneca (AZN) Net Margin (2009 - 2026)
Astrazeneca (AZN) recorded Net Margin of 18.81% in Q2 2026, down 5.79 percentage points from 24.60% a year earlier and down 1.34 percentage points from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Net Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Astrazeneca's Net Margin came in at 17.72% as of Jun 30, 2026, down 1.09 percentage points year-over-year; for FY2025, it came in at 17.41%, up 4.40 percentage points from FY2024.
- Annual Net Margin has increased for four straight years, with a five-year change of +5.40 percentage points (FY2020 to FY2025).
- Across earlier years, Net Margin came in at 13.01% in FY2024 (+0.01 pp), 13.00% in FY2023 (+5.59 pp), 7.41% in FY2022 (+7.11 pp) and 0.30% in FY2021 (-11.71 pp).
- Quarterly Net Margin has ranged from -20.09% in Q3 2021 to 24.60% in Q2 2025 over the past five years.
- On a year-over-year basis, Net Margin rose in four of the last eight quarters, with an average year-over-year change of +2.04 percentage points.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 26.16 percentage points in Q3 2022, against a drop of 36.61 percentage points in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at 20.15% (Q1 2026), 15.00% (Q4 2025) and 16.95% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 22.61% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 18.81% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -1.65% |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 32.99% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.81% |
| Mar 31, 2026 | 20.15% |
| Dec 31, 2025 | 15.00% |
| Sep 30, 2025 | 16.95% |
| Jun 30, 2025 | 24.60% |
| Mar 31, 2025 | 21.46% |
| Dec 31, 2024 | 10.07% |
| Sep 30, 2024 | 19.57% |
| Jun 30, 2024 | 14.92% |
| Mar 31, 2024 | 13.90% |
| Dec 31, 2023 | 14.81% |
| Sep 30, 2023 | 10.92% |
| Jun 30, 2023 | 12.89% |
| Mar 31, 2023 | 20.05% |
| Dec 31, 2022 | 15.28% |
| Sep 30, 2022 | 6.07% |
| Jun 30, 2022 | -3.45% |
| Mar 31, 2022 | 3.56% |
| Dec 31, 2021 | -6.22% |
| Sep 30, 2021 | -20.09% |
API Access
Astrazeneca Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();